About John Patton
Form D filings for Aerami Therapeutics from 2020 to 2023 list John Patton as director.
John Patton first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name John Patton in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people John Patton works with at each company, as listed on that company's latest Form D.
Aerami Therapeutics Holdings, Inc. · Form D, Nov 22, 2023
GB
Gary Burgess
Chief Medical Officer
AW
Anne Whitaker
Chief Executive Officer, Chairwoman of the Board
AS
Adam Stern
Director
ST
Steven Thornton
Director
WW
William Welch
Director
JZ
Joshua Ziel
Chief Operating Officer
DH
Darlene Deptula-Hicks
Chief Financial Officer and Director